Skip to main content

Table 1 Clinical characteristics of examined women with ovarian cancer (n = 149)

From: Antibodies against Hsp60 and Hsp65 in the sera of women with ovarian cancer

Clinical data Number of patients (%)
Antineoplastic treatment:
  • Untreated so far 72 (48,3)
  • After chemotherapy 77 (51,7)
Histopathological type of ovarian cancer:
  • Adenocarcinoma papillare serosum 82 (55,0)
  • Adenocarcinoma mucinosum 44 (29,6)
  • Adenocarcinoma endometrioides 23 (15,4)
Stage of the clinical progresion (by FIGO):
  • I 25 (16,8)
  • II 31 (20,8)
  • III 60 (40,3)
  • IV 33 (22,1)